Delivery Order SPE2DB22D9239-SPE2DB25FDK13
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,434.34 by the Defense Logistics Agency on July 30, 2025, for the supply of Cabometyx 60 mg tablets (30-count units). The delivery order is issued without a set-aside designation and is scheduled for completion by July 31, 2025. This award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 25, 2025, for Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, valued at approximately $33k, represents a single purchase action issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500M vehicle valid...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,434.34 by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Cabometyx 60 mg tablets (30-count packaging). This firm fixed-price delivery order, which has an ultimate completion date of September 19, 2025, represents a single pharmaceutical product delivery under the company's existing indefinite delivery contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $33,265.08 for the supply of Cabometyx 20 mg tablets (30-count units) on September 2, 2025. This award, with an ultimate completion date of September 3, 2025, carries no set-aside designation and will be performed at the contractor's Park Ridge facility. The delivery order is funded by the Defense Logistics Agency's Medical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency valued at $16,632.54 for the supply of Cabometyx 20 mg tablets (30-count). The contract, issued on May 12, 2025, with a completion date of May 13, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, valued at $16,483.21, was issued on September 5, 2025, with an ultimate completion date of September 8, 2025. The award carries no set-aside designation, allowing the company to compete on an open basis despite its...
- The U.S. Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). This award, issued on August 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. The contract utilizes no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency on September 3, 2025, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, was issued without a set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency (DLA) for the supply of Cabometyx 40 mg tablets (30-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a discrete purchase under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order valued at $16,434.34 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 60 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a direct procurement with no set-aside designation. The award reflects performance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 billion...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDK13Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on June 18, 2025, by the Defense Logistics Agency (DLA) for Cabometyx 20 mg tablets (30-count units) with a ceiling value of $33,265.08. The award was made under a firm fixed-price contract type with no set-aside designation, with an ultimate completion date of June 20, 2025. This delivery order represents a purchase of pharmaceutical inventory to support medical supply needs across Department of Defense healthcare facilities. Cabometyx is an oncology medication used in cancer treatment, reflecting DMS Pharmaceutical Group's continued role as a supplier of specialized prescription drugs and therapeutics to federal healthcare systems. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This master contract enables the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products supporting military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract performance, leveraging its woman-owned small business status to compete effectively in federal procurement while delivering an extensive portfolio of prescription medications, biologics, and medical consumables directly to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.3k | 6/18/25 |